There is no licensed formulation, no marketing authorisation, and no completed phase 3 dataset in the public domain
On the basis of several putative modes of action under investigation (for example, neuroprotective and anti-inflammatory properties, regulation of reward pathways), there is an emerging consensus that GLP-1RAs could be repurposed for use in neuropsychiatric conditions 25,26,27,28,29,30,31,32
Past, Present and Future Perspectives in Nonalcoholic Fatty Liver Disease
Opt for a salmon salad, your favorite soups, and fresh fruit
Even with decreases in cardiovascular disease, kidney failure and possible decreases in cancer, employers should be aware that GLP-1 drugs will not lower overall health care costs